Effect of Eugenia jambolana leaves extracts on blood glucose levels of experimental diabetic rabbits

Pharmacologyonline

Volumn 3, Issue , 2009, Pages 829-835

  Qadir, M Imran ^a   Tehzeeb Ul Nisa, ^a   Malik, Salman Akbar ^b  

^a GC UNIVERSITY   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Eugenia jambolana; Hypoglycaemic activity; Leaf extract

Indexed keywords

ALCOHOL; GLIBENCLAMIDE; GLUCOSE; NICOTINAMIDE; STREPTOZOCIN; SYZYGIUM CUMINI EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL RABBIT; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT LEAF; STREPTOZOCIN DIABETES;

EID: 77649319478     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Arky RA. Clinical correlates of metabolic derangements of diabetes mellitus. In: Kozak GP, ed. Complications of Diabetes mellitus. Philadelphia: Saunders WB, 1982:16-20.
2. Valiathan MS. Healing Plants. Current Science 1998;75:1122-1126.
3. Bramachari HD, Augusti KT. Hypoglycaemic agents from Indian indigenous plants. J Pharm Pharmacol 1961;13: 381-382.
4. Rahman AU, Zaman K. Medicinal plants with hypoglycemic activity. J Ethnopharmacol 2001;26: 1-56.
5. Okamato H. Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin dependant diabetes. Mol Cell Biochem 1981;37:43-61.
6. Sridhar SB, Sheetal UD, Pai MRSM, et al. Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats. Braz J Med Biol Res 2005;38(3): 463-468.
7. Masiello P, Broca C, Gross R, et al. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998; 47:224-9.
8. Novelli M, Fabregat ME, Fernandez-Alvarez J, et al. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol 2001;175:57-66.
9. Rebel U, Larsen MO, Rolin B, et al. NN221: A long-acting glucagons-like peptide-1 derivative with antidiabetic in glucose tolerant pigs. Eur J Pharmacol 2002;451:217-25.
10. Larsen MO, Rolin B, Wilken M, et al. Measurements of insulin secretory capacity and glucose intolerance to predict pancreatic cell mass in vivo in the nicotnamide/streptozotocin Göttingen mini pig, a model of moderate insulin deficiency and diabetes. Diabetes 2003;52:118-23.
11. Pepato MT, Folgado VBB, Kettelhut IC, et al. Lack of antidiabetic effect of a Eugenia jambolana leaf decoction on rat streptozotocin diabetes. Braz J Med Biol Res 2001;34(3): 389-395
12. Teixeira CC, Fuchs FD, Weinert LS, et al. The efficacy of folk medicines in the management of type 2 diabetes mellitus: results of a randomizedcontrolled trial of Syzygium cumini (L.) Skeels. J Clin Pharm Therapeut 2006;31: 1-5.
13. Ojewole JA. Laboratory evaluation of the hypoglycaemic effect of Anacardium occidentale linn (Anacardiaceae) stem-bark extracts in rats. Methods find Exp. Clin. Pharmacol 2003;25(3):199-200.
14. Jackson JE, Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents. Part 1. Drugs 1981; 22: 211-245.